Table 5

Cox-regression models for the follow-up duration in 1633 patients who completed the follow-up

VariableMean (SD)Median (range)p ValueHR (95% CI)Total
Age group (years)
    <3010.6 (3.9)10 (7–29)<0.0012.97 (2.53 to 3.50)420
    30–6011.6 (4.4)11 (7–42)1.77 (1.54 to 2.04)835
    >6012.6 (4.1)14 (7–35)1.00378
Sex
    Male10.9 (4.4)10 (7–36)<0.0011.56 (1.41 to 1.72)744
    Female12.2 (4)12 (7–42)1.00889
Predisposing factor
    Mixed factors14.2 (6.3)14 (7–42)<0.0010.29 (0.24 to 0.35)220
    Contact lens wearing12.5 (3.5)12 (7–32)0.42 (0.36 to 0.48)524
    Corneal trauma12.5 (3.2)12 (7–23)0.41 (0.33 to 0.51)110
    Ocular disease11 (3.9)10 (7–26)0.53 (0.46 to 0.62)396
    Systemic illness10.4 (3.7)10 (7–22)0.60 (0.46 to 0.77)75
    Undefined8.8 (2.4)7 (7–17)1.00308
Presenting visual acuity
    ⩾6/610.2 (2.8)10 (7–21)<0.0014.02 (2.82 to 5.71)685
    6/911.3 (3.6)10 (7–28)3.11 (2.18 to 4.44)359
    6/1212.4 (4.8)12 (7–36)2.39 (1.67 to 3.42)303
    6/1813.1 (5.2)12 (7–36)2.14 (1.47 to 3.11)140
    6/2413.8 (4.7)14 (7–35)1.91 (1.26 to 2.89)67
    6/3615.3 (5.7)16 (7–35)1.56 (1.00 to 2.45)44
    ⩽6/6019.1 (6.4)20 (10–42)1.0035
Ulcer location
    Central14.4 (5.3)13 (7–42)<0.0010.49 (0.41 to 0.57)411
    Paracentral12.4 (4.1)12 (7–35)0.60 (0.50 to 0.71)252
    Midperipheral10.2 (3.1)10 (7–24)0.88 (0.77 to 1.01)629
    Marginal10.2 (2.8)10 (7–22)1.00341
Ulcer size
    Large22.8 (6.5)20 (14–42)<0.0010.21 (0.14 to 0.30)38
    Medium17.9 (5.6)18 (10–35)0.33 (0.27 to 0.42)100
    Small10.9 (3.2)10 (7–28)1.001495
Microbial infections
    Bacteria+acanthamoeba29.4 (5.9)29 (22–42)<0.0010.0811
    Bacteria+fungus23 (3.4)24 (17–72)0.11 (0.05 to 0.27)8
    Bacteria+virus12.8 (3.7)12 (7–27)0.32 (0.22 to 0.47)62
    Bacteria+chlamydia12.5 (4.5)12 (7–20)0.62 (0.38 to 1.37)12
    Viral12.1 (3.8)10 (7–24)0.44 (0.33 to 0.60)423
    Pure bacterial11.6 (4.2)11 (7–35)0.67 (0.50 to 0.90)650
    Negative cultures10.5 (2.9)10 (7–19)0.75 (0.55 to 1.01)415
    Undefined8 (2)7 (7–14)1.0052